Theoretically, correction of the biochemical abnormality to suppress possible adverse effects would be the therapeutic target, and as evidenced in the first proven individual with GNMT deficiency a low methionine diet (300 mg/day) can correct the biochemical abnormalities (Mudd et al 2001b). The gene discussed is GNMT; the disease is hyperinsulinemic hypoglycemia, familial, 4.